THE GALD ASSAY
A Lectin-Based Quantification of Serum Galactose-deficient IgA1
4-hour turn around
Based on the Novak Assay
All-in-one easy to implement kit
Serum levels of Gd-IgA1 represent the most utilized disease-specific biomarker in IgA nephropathy
The GalD Assay will include calibration standards, QC's, blanks, and reagants to analyze 36 patient samples in duplicate.
IGAN PATIENT VS. HEALTHY CONTROLS
Statistically significant separation (p=0.0105) observed in Gd-IgA1 serum levels as measured by the GalD Assay
IgA nephropathy patients (n=29) and healthy controls (n=12)
LAUNCHING IN SPRING 2024
The GalD Assay from Reliant Glycosciences
*For research purposes only*
ADD YOUR NAME TO THE LIST
By adding your name to the list for The GalD Assay, we will follow up with you shortly!